Delegates who would like to present their work at the meeting, either orally or as a poster, are invited to submit an abstract for consideration by the Scientific Committee.
There are no fees to submit an abstract; submit your abstract for free today!
Please find the full Abstract Submission Guidelines below:
You will be asked to define which SSC Subcommittees and working groups your abstract most aligns with from the following list:
|Section One - Platelets:
Signal transduction in platelets
Molecular basis of inherited or acquired platelet disorders
Clinical aspects of Inherited platelet disorders
Clinical aspects of Acquired platelet disorders
Platelets in transfusion medicine
|Section Two - Coagulation Factors
Contact phase activation
Exogenous hemostatic factors
Fibrinogen and other factors
|Section Three - Thrombotic Disorders
Deep vein thrombosis and pulmonary embolism
Genetic determinants and epidemiology
Disseminated intravascular coagulation
Thrombotic disorders in children
Thrombotic disorders in women
Cancer and thrombosis – clinical
Cancer and thrombosis – basic science
|Section Four - Bleeding Disorders
von Willebrand Disease
Other inherited bleeding disorders
Acquired bleeding disorders
Bleeding disorders in children
Bleeding disorders in women
Innovative therapies for bleeding disorders
|Section Five - Fibrinolysis and Proteolysis
Plasminogen and plasminogen activators
Plasminogen activator inhibitors
PA system in organ-specific disorders
Fibrinogen and fibrin
New thrombolytic agents and drug design
|Section Six - Vascular Biology
Inflammatory cells and cytokines
Endothelial Progenitor Cells
|Section Seven - Hematopoiesis
Progenitor Cells and Stem Cells
The keyboard configuration of computers in non-Western countries may cause problems with the printing of the abstracts when special non-Western characters are used. To avoid these problems the language setting of your computer should be changed. To do this select "Start" then Settings", then "Control Panel" and then choosing "Keyboard." Once in this menu, set the language of your computer to English (United States) or US (International). Next, open MS Word (or the word processing software you are using) and set the font type to Arial. In the preparation of your abstract, if you require certain special characters that are not available, (e.g. '±', '®', 'μ'), use the insert symbol feature (special characters). To do this, select Arial as the font (unicoded, if possible), then select the required character, and copy and paste the symbol into the text of the abstract. If a special character is still not available, describe the character, e.g. 'alpha’.
Before submitting your abstract, select Unicode as the preferred font. If Unicode is not available, please select Western.
An international panel of experts will review the abstracts. Each abstract will be reviewed by 4-6 different experts.
The reviewers will judge the abstracts according to the following criteria:
The first author will be notified in March 2016, at the email address provided during submission, about whether or not their abstract has been accepted.
Poster presenters will be informed about the date of the poster exhibition and will receive guidelines for their preparation and presentation. Posters will be organized within the session using the topics chosen by the submitter in the online system.
All accepted abstracts will be published as addendum supplement to the Journal of Thrombosis and Haemostasis and will be made available on the ISTH 2016 SSC website at the time of the meeting.
If authors wish to withdraw their abstracts from presentation or publication they are requested to send a letter via e-mail to firstname.lastname@example.org before April 1, 2016.
Withdrawn abstracts cannot be presented nor will these be published.
All abstracts submitted by February 1 will be reviewed by an international panel of experts (representing all subspecialties from a large number of countries). Within 10 days after the closure of the abstract submission, the reviewers are requested to read and score each abstract in their category based on scientific merit. The scoring system is a scale ranging from 1 to 10, with a qualitative explanation of each grade. Once all abstracts have been reviewed, the scores are normalized and averaged.
The Scientific Committee will reward abstracts of outstanding quality and provide the submitting author with a Travel Grant to attend the SSC 2016 meeting. Two categories of Travel Grants will be available in limited number to the abstract submitters.
The Young Investigators Awards are provided in the form of travel grants to medical trainees and young scientists (under 35 years of age as of May 24, 2016) who submit a highly rated abstract. Travel grants are specifically intended to help with travel to the Meeting. In order to be considered for an award, the Young Investigator must be the first author on an abstract submitted to the Meeting.
The highest rated abstract in each SSC Subcommittee Category will be selected for an Oral Presentation in that session and will be eligible for an ISTH Travel Grant. Please note that you need to be willing to submit this presentation orally.
To be eligible for the award, the recipient must attend the Meeting, and members of the ISTH will be given priority.
The ISTH will award travel grants to clinicians and scientists from developing countries (countries classified by the World Bank as low income, lower-middle income, or upper-middle income)
to help subsidize travel to the Meeting (a copy of current passport showing country of residence will be required). Those that are the presenter and first author of an abstract submitted to the Meeting will be prioritized. To be eligible for the award, the recipient must attend the Meeting.
Please select the relevant award on the drop down on the abstract submission form to indicate you wish to apply for this grant.
For those not submitting abstracts, please apply to email@example.com and explain how this grant and meeting will be of benefit in driving up standards of care for patients. To be eligible for the award, the recipient must attend the Meeting.
If you experience any kind of problem or if you have questions, please do not hesitate to contact PharmaService at firstname.lastname@example.org.